Showing results (131-140 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|July 13, 2022
Preclinical development of a vaccine-based immunotherapy regimen (VBIR) that induces potent and durable T cell responses to tumor-associated self-antigensHelen Cho, Joe Binder, Risini Weeratna, et al.Cancer Immunology, Immunotherapy : CII|July 16, 2022
Cytokine alterations during paraneoplastic neutrophilia and leukemoid reaction in patients with advanced melanomaXin-Wen Zhang, Alexander Wald, Martin Salzmann, et al.Cancer Immunology, Immunotherapy : CII|September 6, 2017
Immune profiling of melanoma tumors reflecting aggressiveness in a preclinical modelSotirios P Fortis, Louisa G Mahaira, Eleftheria A Anastasopoulou, et al.Cancer Immunology, Immunotherapy : CII|September 30, 2016
Anti-PD-1 inhibits Foxp3+ Treg cell conversion and unleashes intratumoural effector T cells thereby enhancing the efficacy of a cancer vaccine in a mouse modelLydia Dyck, Mieszko M Wilk, Mathilde Raverdeau, et al.Cancer Immunology, Immunotherapy : CII|September 23, 2019
Conventional CARs versus modular CARsAnja Feldmann, Claudia Arndt, Stefanie Koristka, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1985
The effect of indomethacin on the activation and effector function of suppressor cells from tumor-bearing miceB L PopeCancer Immunology, Immunotherapy : CII|January 1, 1985
Immune response of mice exposed to cis-diamminedichloroplatinumO Bagasra, L Currao, L R DeSouza, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1985
The effects of thymic epithelial monolayer-conditioned medium on suppressor cell function following chemotherapy in pediatric patientsM S Borzy, D RidgwayCancer Immunology, Immunotherapy : CII|March 5, 2019
Absolute numbers of regulatory T cells and neutrophils in corticosteroid-free patients are predictive for response to bevacizumab in recurrent glioblastoma patientsVéronique Quillien, Antoine F Carpentier, Alain Gey, et al.Cancer Immunology, Immunotherapy : CII|November 16, 2018
Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderlyWagner A Poles, Erika E Nishi, Mariana B de Oliveira, et al.Pageof 650